Cardiac Bio Implant Devices Market

Cardiovascular implants have unique blood biocompatibility property, to ensure that the device is not rejected due to adverse thrombogenic or hemodynamic blood responses. There are various implantable cardiac devices such as cardiovascular stent, left ventricular assisted device, pacemakers, artificial hearts, defibrillators and vascular grafts. Pacemakers help in controlling the abnormal heart rhythm. Similarly, implantable defibrillator prevents cardiac arrest. Cardiac implant is composed of polymeric material such as hydrolytically degradable polyesters.

Cardiac Bio Implant Devices Market contains market size and forecasts of Cardiac Bio Implant Devices in global, including the following market information:

Global Cardiac Bio Implant Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Cardiac Bio Implant Devices Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Cardiac Bio Implant Devices companies in 2021 (%)

The global Cardiac Bio Implant Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Implantable Cardioverter Defibrillators (ICD) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cardiac Bio Implant Devices include Abbott Laboratories, Edwards Lifesciences, Johnson & Johnson, Sorin, Medtronic, Boston Scientific, Terumo, Lepu Medical and MicroPort, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Cardiac Bio Implant Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cardiac Bio Implant Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cardiac Bio Implant Devices Market Segment Percentages, by Type, 2021 (%)

Implantable Cardioverter Defibrillators (ICD)

Implantable Cardiac Pacemakers (ICP)

Heart Valve

Coronary Stent

Peripheral Stent

Ventricular Assist Device

Global Cardiac Bio Implant Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cardiac Bio Implant Devices Market Segment Percentages, by Application, 2021 (%)

Myocardial Ischemia

Acute Myocardial Infarction

Arrhythmias

Others

Global Cardiac Bio Implant Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cardiac Bio Implant Devices Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cardiac Bio Implant Devices revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Cardiac Bio Implant Devices revenues share in global market, 2021 (%)

Key companies Cardiac Bio Implant Devices sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Cardiac Bio Implant Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abbott Laboratories

Edwards Lifesciences

Johnson & Johnson

Sorin

Medtronic

Boston Scientific

Terumo

Lepu Medical

MicroPort

Biosensors

B.Braun

Atrium Medical

Biotronik

SINOMED